Article    Table of Contents                    Full Text of this article Free    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Markowitz, N.    Reichman, L. B.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons

Norman Markowitz; Nellie I. Hansen; Timothy C. Wilcosky; Philip C. Hopewell; Jeffrey Glassroth; Paul A. Kvale; Bonita T. Mangura; Dennis Osmond; Jeanne M. Wallace; Mark J. Rosen; and Lee B. Reichman

1 August 1993 | Volume 119 Issue 3 | Pages 185-193

Objective: To determine the prevalence and predictors of reactivity to tuberculin purified protein derivative (PPD) and skin test anergy in patients with human immunodeficiency virus (HIV) infection and in HIV-seronegative controls.

Design: Cross-sectional analysis of baseline data from a prospective, multicenter study of pulmonary complications of HIV infection.

Setting: Community-based cohort of persons with and without HIV infection.

Patients: A total of 1171 HIV-seropositive patients without AIDS (841 homosexual men, 274 intravenous drug users, and 56 women with heterosexually acquired infection); 182 HIV-seronegative persons (125 homosexual men and 57 intravenous drug users).

Measurements: Delayed-type hypersensitivity response to tuberculin PPD, trichophytin, mumps, and Candida antigens; T-lymphocyte subsets.

Results: The prevalence of tuberculin PPD reactivity was higher among intravenous drug users than among homosexual men, in both HIV-seronegative (19.1% compared with 6.8%, P = 0.03) and HIV-seropositive persons (15.1% compared with 2.5%, P < 0.001). Among HIV-infected patients, the prevalence of tuberculin reactivity varied directly and that of anergy inversely with the absolute CD4 lymphocyte count. Prevalences were 1% and 72%, respectively, in patients with fewer than 200 CD4 cells/mm³, and 8.4% and 25.5%, respectively, in those with 600 CD4 cells/mm³ (P < 0.001 for both comparisons). Patients with HIV infection and fewer than 400 CD4 lymphocytes/mm³ had a lower prevalence of PPD reactivity than HIV-seronegative controls (2.7% compared with 10.0%, P < 0.001). The strongest predictors of tuberculin reactivity were intravenous drug use, black race, a previous positive PPD test result, and a history of Calmette–Guérin bacillus vaccination. The strongest predictor of anergy was HIV seropositivity.

Conclusions: The response to delayed-type hypersensitivity antigens depends on immune status. The value of PPD and anergy testing in HIV-seropositive patients depends on the ability of such testing to predict subsequent tuberculosis, which is imprecisely known. Until more data or better methods are available, these tests should be done as early as possible in the course of HIV infection.

*For participating institutions and investigators, see the Appendix.

Author and Article Information

Pulmonary Complications of HIV Infection Study Group*
Requests for Reprints: Norman Markowitz, MD, Henry Ford Hospital, Division of Infectious Diseases, 2799 West Grand Boulevard, Detroit, MI 48202.
Grant Support: In part by contracts N01-HR7-6029, –6030,-6031, –6032,-6033, –6034,and –6035 with the National Heart, Lung, and Blood Institute. Co-sponsored by the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Related articles in Annals:

Articles
Delayed-Type Hypersensitivity Skin Testing Predicts Progression to AIDS in HIV-infected Patients
Stephen P. Blatt, Craig W. Hendrix, Clifford A. Butzin, Theodore M. Freeman, William W. Ward, Rex E. Hensley, Gregory P. Melcher, Daniel J. Donovan, AND R. Neal Boswell

Annals 1993 119: 177-184. [ABSTRACT][Full Text]  

Articles
Risk for Developing Tuberculosis among Anergic Patients Infected with HIV
Santiago Moreno, Josu Baraia-Etxaburu, Emilio Bouza, Francisco Parras, Miguel Perez-Tascon, Pilar Miralles, Teresa Vicente, Juan C. Alberdi, Jaime Cosn, AND Dulce Lopez-Gay

Annals 1993 119: 194-198. [ABSTRACT][Full Text]  

Editorials
Skin Test Responses as Predictors of Tuberculous Infection and of Progression in HIV-infected Persons
Richard S. Kornbluth

Annals 1993 119: 241-243. [Full Text]  

This article has been cited by other articles:

				M. X. Rangaka, K. A. Wilkinson, R. Seldon, G. Van Cutsem, G. A. Meintjes, C. Morroni, P. Mouton, L. Diwakar, T. G. Connell, G. Maartens, et al. Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 514 - 520. [Abstract] [Full Text] [PDF]

				B. Tegbaru, D. Wolday, T. Messele, M. Legesse, Y. Mekonnen, F. Miedema, and D. van Baarle Tuberculin Skin Test Conversion and Reactivity Rates among Adults with and without Human Immunodeficiency Virus in Urban Settings in Ethiopia. Clin. Vaccine Immunol., July 1, 2006; 13(7): 784 - 789. [Abstract] [Full Text] [PDF]

				C. Reed, C. F. von Reyn, S. Chamblee, T. V. Ellerbrock, J. W. Johnson, B. J. Marsh, L. S. Johnson, R. J. Trenschel, and C. R. Horsburgh Jr. Environmental Risk Factors for Infection with Mycobacterium avium Complex Am. J. Epidemiol., July 1, 2006; 164(1): 32 - 40. [Abstract] [Full Text] [PDF]

				D. Trabattoni, M. Saresella, M. Biasin, A. Boasso, L. Piacentini, P. Ferrante, H. Dong, R. Maserati, G. M. Shearer, L. Chen, et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression Blood, April 1, 2003; 101(7): 2514 - 2520. [Abstract] [Full Text] [PDF]

				R. M. Jasmer, P. Nahid, and P. C. Hopewell Latent Tuberculosis Infection N. Engl. J. Med., December 5, 2002; 347(23): 1860 - 1866. [Full Text] [PDF]

				A. S. Rogers, J. H. Ellenberg, S. D. Douglas, L. Henry-Reid, L. Peralta, C. M. Wilson, and The Adolescent Medicine HIV/AIDS Research Network Performance of Antigens Used in Detecting Delayed-Type Hypersensitivity in Adolescents Infected with the Human Immunodeficiency Virus Clin. Vaccine Immunol., March 1, 2001; 8(2): 273 - 278. [Abstract] [Full Text] [PDF]

				B. S. Slovis, J. D. Plitman, and D. W. Haas The Case Against Anergy Testing as a Routine Adjunct to Tuberculin Skin Testing JAMA, April 19, 2000; 283(15): 2003 - 2007. [Abstract] [Full Text] [PDF]

				Diagnostic Standards and Classification of Tuberculosis in Adults and Children . This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999 Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1376 - 1395. [Full Text]

				Ma. de Lourdes Garcia-Garcia, J. L. Valdespino-Gomez, C. Garcia-Sancho, Ma. E. Mayar-Maya, M. Palacios-Martinez, S. Balandrano-Campos, A. Escobar-Gutierrez, A. Peruga, M. Weissenbacher, and E. Daniels Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel Int. J. Epidemiol., April 1, 2000; 29(2): 369 - 375. [Abstract] [Full Text] [PDF]

				K. SCHWARTZMAN and D. MENZIES Tuberculosis Screening of Immigrants to Low-Prevalence Countries . A Cost-effectiveness Analysis Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 780 - 789. [Abstract] [Full Text] [PDF]

				D. Ashkin, E. S. Hollender, and M. Narita "Won't Get Fooled Again" (by Tuberculosis) Chest, October 1, 1999; 116(4): 856 - 857. [Full Text] [PDF]

				D. Menzies, T. N. Tannenbaum, and J. M. FitzGerald Tuberculosis: 10. Prevention Can. Med. Assoc. J., September 1, 1999; 161(6): 717 - 724. [Full Text] [PDF]

				J. M. FitzGerald and S. Houston Tuberculosis: 8. The disease in association with HIV infection Can. Med. Assoc. J., July 1, 1999; 161(1): 47 - 51. [Abstract] [Full Text] [PDF]

				A. M. Mandalakas, L. Guay, P. Musoke, C. Carroll-Pankhurst, and K. N. Olness Human Immunodeficiency Virus Status and Delayed-Type Hypersensitivity Skin Testing in Ugandan Children Pediatrics, February 1, 1999; 103(2): 21e - 21. [Abstract] [Full Text]

				J. L. JOHNSON, S. NYOLE, A. OKWERA, C. C. WHALEN, P. NSUBUGA, V. PEKOVIC, R. HUEBNER, R. S. WALLIS, P. N. MUGYENYI, R. D. MUGERWA, et al. Instability of Tuberculin and Candida Skin Test Reactivity in HIV-infected Ugandans Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1790 - 1796. [Abstract] [Full Text] [PDF]

				F. M. Gordin, J. P. Matts, C. Miller, L. S. Brown, R. Hafner, S. L. John, M. Klein, A. Vaughn, C. L. Besch, G. Perez, et al. A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis N. Engl. J. Med., July 31, 1997; 337(5): 315 - 320. [Abstract] [Full Text] [PDF]

				J. LOUTHER, P. RIVERA, J. FELDMAN, N. VILLA, J. D. HOVITZ, and K. A. SEPKOWITZ Risk of Tuberculin Conversion According to Occupation among Health Care Workers at a New York City Hospital Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 201 - 205. [Abstract] [Full Text]

				L. Meyaard, E. Hovenkamp, N. Pakker, T. C.T.M. van der Pouw Kraan, and F. Miedema Interleukin-12 (IL-12) Production in Whole Blood Cultures From Human Immunodeficiency Virus-Infected Individuals Studied in Relation to IL-10 and Prostaglandin E2 Production Blood, January 15, 1997; 89(2): 570 - 576. [Abstract] [Full Text] [PDF]

				C. L. DALEY, J. A. HAHN, A. R. MOSS, P. C. HOPEWELL, and G. F. SCHECTER Incidence of Tuberculosis in Injection Drug Users in San Francisco . Impact of Anergy Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 19 - 22. [Abstract] [Full Text]

				R. H. Goldschmidt, N. Hearst, D. B. Chambers, A. S. Zbrozek, C. F. von Reyn, S. T. Brown, R. D. Arbeit, L. B. Reichman, R. J. McDonald, B. T. Mangura, et al. Rifabutin Prophylaxis against Mycobacterium avium Complex Infection N. Engl. J. Med., February 10, 1994; 330(6): 436 - 438. [Full Text]

				THE VALUE OF SKIN TESTING IN HIV-INFECTED PATIENTS Journal Watch (General), August 13, 1993; 1993(813): 1 - 1. [Full Text]